At Lonza we always welcome interest and inquiries from the media about our business, services and capabilities. Please use the resources on this page, or contact our media relations team for specific inquiries, and we will connect you to the appropriate business leader or subject matter expert.

17 April 2020
Lonza Reports Solid Q1 2020 Performance, with Segments Continuing to Deliver...
Due to COVID-19, Lonza provides the following update outside of the regular reporting cycle: Group net sales reached CHF1.6 billion in Q1, up 7.4%...
23 March 2020
Lonza Launches New TheraPEAK™ SfAAV™ Medium to Boost and Optimize the Production...
Lonza has launched a new medium to enhance and accelerate the production of Adeno Associated Virus (AAV) in Spodoptera Fuigiperda (Sf9) insect...
17 April 2020
Lonza Reports Solid Q1 2020 Performance, with Segments Continuing to Deliver...
Due to COVID-19, Lonza provides the following update outside of the regular reporting cycle: Group net sales reached CHF1.6 billion in Q1, up 7.4%...